In a bold move to position itself as a global science leader, the European Union, in partnership with France, has unveiled a €500 million ($566 million) fund aimed at attracting top researchers, especially from the United States, amid deep cuts to American science funding.
Announced during the “Choose Europe for Science” event at Sorbonne University, the initiative is designed to counter recent U.S. policy shifts that have restricted research budgets, diversity-focused programs, and academic visas. European Commission President Ursula von der Leyen and French President Emmanuel Macron led the launch, emphasizing Europe’s commitment to freedom in research and scientific innovation.
“Science holds the key to our future,” said von der Leyen. “At a time when others are stepping back, Europe is stepping up.”
What Is the ‘Choose Europe’ Science Initiative?
The initiative includes several key features designed to attract top talent. Notably, the European Research Council will offer super grants to support high-impact scientific projects. Early-career researchers will benefit from enhanced incentives, such as longer-term contracts and increased funding. Bonuses for scientists moving to EU institutions have doubled to make relocation more appealing. Additionally, France has pledged an extra €100 million to further strengthen the program and support incoming researchers.
Targeting U.S. Scientists After Trump-Era Cuts
Although von der Leyen avoided naming the U.S. directly, Macron was more explicit:
“One of the world’s largest democracies has cancelled programs over words like ‘diversity’ and restricted visas for scientists,” Macron said. “This is a mistake we aim to correct by welcoming those minds here.”
Recent U.S. policy changes include:
- A $2.3 billion funding freeze at Harvard University.
- Dozens of grant suspensions at Princeton.
- Major cuts to the National Institutes of Health (NIH), threatening research in cancer, Alzheimer’s, and diabetes.
Prominent researchers like Peter Lurie are already suing the U.S. government over NIH budget slashes, warning that these decisions jeopardize America’s leadership in medical research.
Early Success & Global Interest
Europe’s strategy is already gaining significant traction. The “Choose France for Science” platform has attracted over 30,000 visitors from 157 countries, with 34% of the traffic originating from the United States. This growing interest has translated into hundreds of applications from scientists seeking to relocate to EU institutions. In response, leading institutions such as Aix-Marseille University in France and Germany’s Max Planck Society have launched dedicated programs to support researchers affected by funding cuts and policy shifts in their home countries.
Challenges Ahead for Europe
Despite the momentum, hurdles remain:
- European universities often operate with smaller budgets than their U.S. counterparts.
- Research salaries in Europe can be less competitive.
- Bureaucratic red tape continues to slow hiring and funding processes.
To address these concerns, von der Leyen announced:
- A new European Research Area Act to ease knowledge and data flow.
- A European Innovation Act to streamline tech transfer from labs to the market.
Looking Ahead: EU’s Vision for Scientific Leadership
The EU has set an ambitious goal: to invest 3% of its GDP in research and development by 2030. Building on its €95 billion Horizon Europe program, which has supported 33 Nobel Prize winners, the EU aims to lead in fields like Artificial Intelligence (AI), Quantum Computing, Space Technology, and Biotechnology
“Progress thrives on freedom, openness, and collaboration,” von der Leyen concluded. “To the world’s scientists: Choose Science. Choose Europe.”
What does it mean for the Future of Global Science?
As U.S. research institutions face funding rollbacks and political constraints, Europe is stepping up. A 32% surge in American scientists applying to overseas programs this year signals a potential brain drain—and a major opportunity for Europe to redefine the global scientific landscape.
